Skip to main content
Erschienen in: Annals of Surgical Oncology 6/2010

01.06.2010 | Bone and Soft Tissue Sarcomas

Aggressive Surgery in Retroperitoneal Soft Tissue Sarcoma Carried Out at High-Volume Centers is Safe and is Associated With Improved Local Control

verfasst von: Sylvie Bonvalot, MD, PhD, Rosalba Miceli, PhD, Mattia Berselli, MD, Sylvain Causeret, MD, Chiara Colombo, MD, Luigi Mariani, MD, Hatem Bouzaiene, MD, Cécile Le Péchoux, MD, Paolo Giovanni Casali, MD, Axel Le Cesne, MD, Marco Fiore, MD, Alessandro Gronchi, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

We sought to assess morbidity and mortality in primary retroperitoneal soft tissue sarcomas (RSTS) treated by a frontline aggressive surgical approach.

Methods

A total of 249 consecutive patients with primary RSTS were treated by a frontline aggressive surgical approach at two major European institutions. Multivariable models were used for exploring the relationship between postsurgical morbidity and the number of organs resected, with adjustment for clinical variables. The impact of morbidity on local and distant recurrence-free survival was explored by multivariable models, adjusting for the main known prognostic factors.

Results

Median follow-up was 37 months (interquartile [IQ] range, 16–61 months). Median tumor size was 17 cm (IQ range, 11–26 cm). The median number of organs resected en bloc with the tumor was 2 (IQ range, 1–3). Complete macroscopic resection was achieved in 232 cases (93%). At 5 years, overall survival was 65.4% (95% confidence interval [95% CI], 56.8–72.7); local and distant recurrence crude cumulative incidences were 22.3% (95% CI, 16.5–30.2) and 24.2% (95% CI, 18.4–31.9), respectively. Postsurgical morbidity requiring at least one invasive therapeutic procedure was observed in 45 patients (18%; 95% CI, 14–23). Surgical reintervention was necessary in 30 patients (12%; 95% CI, 8–17). Eight patients died of postoperative complications (3%; 95% CI, 1–6). No statistically significant association between postsurgical morbidity and any clinical variable was detected. For number of resected organs, we documented an increased risk of morbidity for more than three organs (P = 0.007). Postsurgical morbidity did not affect oncologic outcome.

Conclusions

Frontline aggressive surgical approach to primary RSTS is safe when carried out at high-volume centers. It could be systematically considered in primary RSTS.
Literatur
1.
Zurück zum Zitat Gronchi A, Lo Vullo S, Fiore M, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol. 2009;27:24–30.CrossRefPubMed Gronchi A, Lo Vullo S, Fiore M, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol. 2009;27:24–30.CrossRefPubMed
2.
Zurück zum Zitat Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009;27:31–7.CrossRefPubMed Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009;27:31–7.CrossRefPubMed
3.
Zurück zum Zitat Pisters PW. Resection of some—but not all—clinically uninvolved adjacent viscera as part of surgery for retroperitoneal soft tissue sarcomas. J Clin Oncol. 2009;27:6–8.CrossRefPubMed Pisters PW. Resection of some—but not all—clinically uninvolved adjacent viscera as part of surgery for retroperitoneal soft tissue sarcomas. J Clin Oncol. 2009;27:6–8.CrossRefPubMed
4.
Zurück zum Zitat Gronchi A, Bonvalot S, Le Cesne A, Casali PG. Resection of uninvolved adjacent organs can be part of surgery for retroperitoneal soft tissue sarcoma. J Clin Oncol. 2009;27:2106–7.CrossRefPubMed Gronchi A, Bonvalot S, Le Cesne A, Casali PG. Resection of uninvolved adjacent organs can be part of surgery for retroperitoneal soft tissue sarcoma. J Clin Oncol. 2009;27:2106–7.CrossRefPubMed
6.
Zurück zum Zitat Trojani M, Contesso G, Coindre JM, et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer. 1984;33:37–42.CrossRefPubMed Trojani M, Contesso G, Coindre JM, et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer. 1984;33:37–42.CrossRefPubMed
7.
Zurück zum Zitat Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med. 1989;8:551–61.CrossRefPubMed Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med. 1989;8:551–61.CrossRefPubMed
8.
Zurück zum Zitat Marubini E, Valsecchi MG. Analysing Survival Data for Clinical Trials and Observational Studies. Chichester: Wiley; 1995. Marubini E, Valsecchi MG. Analysing Survival Data for Clinical Trials and Observational Studies. Chichester: Wiley; 1995.
9.
Zurück zum Zitat Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69:239–41.CrossRef Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69:239–41.CrossRef
10.
Zurück zum Zitat R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. Vienna, Austria: R Development, 2006. Available at: http://www.R-project.org. Accessed 24 June 2009. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. Vienna, Austria: R Development, 2006. Available at: http://​www.​R-project.​org. Accessed 24 June 2009.
11.
Zurück zum Zitat Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg. 1998;228:355–65.CrossRefPubMed Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg. 1998;228:355–65.CrossRefPubMed
12.
Zurück zum Zitat Stoeckle E, Coindre JM, Bonvalot S, et al. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer. 2001;92:359–68.CrossRefPubMed Stoeckle E, Coindre JM, Bonvalot S, et al. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer. 2001;92:359–68.CrossRefPubMed
13.
Zurück zum Zitat Ferrario T, Karakousis CP. Retroperitoneal sarcomas: grade and survival. Arch Surg. 2003;138:248–51.CrossRefPubMed Ferrario T, Karakousis CP. Retroperitoneal sarcomas: grade and survival. Arch Surg. 2003;138:248–51.CrossRefPubMed
14.
Zurück zum Zitat Gronchi A, Casali PG, Fiore M, et al. Retroperitoneal soft tissue sarcomas: patterns of recurrence in 167 patients treated at a single institution. Cancer. 2004;100:2448–55.CrossRefPubMed Gronchi A, Casali PG, Fiore M, et al. Retroperitoneal soft tissue sarcomas: patterns of recurrence in 167 patients treated at a single institution. Cancer. 2004;100:2448–55.CrossRefPubMed
15.
Zurück zum Zitat Kilkenny JW III, Bland KI, Copeland EM III. Retroperitoneal sarcoma: the University of Florida experience. J Am Coll Surg. 1996;182:329–39.PubMed Kilkenny JW III, Bland KI, Copeland EM III. Retroperitoneal sarcoma: the University of Florida experience. J Am Coll Surg. 1996;182:329–39.PubMed
16.
Zurück zum Zitat Hassan I, Park SZ, Donohue JH, et al. Operative management of primary retroperitoneal sarcomas: a reappraisal of an institutional experience. Ann Surg. 2004;239:244–50.CrossRefPubMed Hassan I, Park SZ, Donohue JH, et al. Operative management of primary retroperitoneal sarcomas: a reappraisal of an institutional experience. Ann Surg. 2004;239:244–50.CrossRefPubMed
17.
Zurück zum Zitat van Dalen T, Plooij JM, van Coevorden F, et al. Long-term prognosis of primary retroperitoneal soft tissue sarcoma. Eur J Surg Oncol. 2007;33:234–8.CrossRefPubMed van Dalen T, Plooij JM, van Coevorden F, et al. Long-term prognosis of primary retroperitoneal soft tissue sarcoma. Eur J Surg Oncol. 2007;33:234–8.CrossRefPubMed
18.
Zurück zum Zitat Ballo MT, Zagars GK, Pollock RE, et al. Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys. 2007;67:158–63.PubMed Ballo MT, Zagars GK, Pollock RE, et al. Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys. 2007;67:158–63.PubMed
19.
Zurück zum Zitat Lehnert T, Cardona S, Hinz U, et al. Primary and locally recurrent retroperitoneal sarcoma: local control and survival. Eur J Surg Oncol. 2009;35:986–93.PubMed Lehnert T, Cardona S, Hinz U, et al. Primary and locally recurrent retroperitoneal sarcoma: local control and survival. Eur J Surg Oncol. 2009;35:986–93.PubMed
20.
Zurück zum Zitat Anaya DA, Lahat G, Wang X, et al. Establishing prognosis in retroperitoneal sarcoma: a new histology-based paradigm. Ann Surg Oncol. 2009;16:667–75.CrossRefPubMed Anaya DA, Lahat G, Wang X, et al. Establishing prognosis in retroperitoneal sarcoma: a new histology-based paradigm. Ann Surg Oncol. 2009;16:667–75.CrossRefPubMed
21.
Zurück zum Zitat Bonvalot S, Cavalcanti A, Le Péchoux C, et al. Randomized trial of cytoreduction followed by intraperitoneal chemotherapy versus cytoreduction alone in patients with peritoneal sarcomatosis. Eur J Surg Oncol. 2005;31:917–23.CrossRefPubMed Bonvalot S, Cavalcanti A, Le Péchoux C, et al. Randomized trial of cytoreduction followed by intraperitoneal chemotherapy versus cytoreduction alone in patients with peritoneal sarcomatosis. Eur J Surg Oncol. 2005;31:917–23.CrossRefPubMed
22.
Zurück zum Zitat Park DJ, Lee HJ, Kim HH, et al. Predictors of operative morbidity and mortality in gastric cancer surgery. Br J Surg. 2005;92:1099–102.CrossRefPubMed Park DJ, Lee HJ, Kim HH, et al. Predictors of operative morbidity and mortality in gastric cancer surgery. Br J Surg. 2005;92:1099–102.CrossRefPubMed
23.
Zurück zum Zitat Vin Y, Sima CS, Getrajdman GI, et al. Management and outcomes of postpancreatectomy. fistula, leak, and abscess: results of 908 patients resected at a single institution between 2000 and 2005. J Am Coll Surg. 2008;207:490–8.CrossRefPubMed Vin Y, Sima CS, Getrajdman GI, et al. Management and outcomes of postpancreatectomy. fistula, leak, and abscess: results of 908 patients resected at a single institution between 2000 and 2005. J Am Coll Surg. 2008;207:490–8.CrossRefPubMed
24.
Zurück zum Zitat Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1803 consecutive cases over the past decade. Ann Surg. 2002;236:397–406.CrossRefPubMed Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1803 consecutive cases over the past decade. Ann Surg. 2002;236:397–406.CrossRefPubMed
25.
Zurück zum Zitat Sah BK, Zhu ZG, Chen MM, et al. Effect of surgical work volume on postoperative complication: superiority of specialized center in gastric cancer treatment. Langenbecks Arch Surg. 2009;394:41–7.CrossRefPubMed Sah BK, Zhu ZG, Chen MM, et al. Effect of surgical work volume on postoperative complication: superiority of specialized center in gastric cancer treatment. Langenbecks Arch Surg. 2009;394:41–7.CrossRefPubMed
26.
Zurück zum Zitat van Heek NT, Kuhlmann KFD, Scholten RJ, et al. Hospital volume and mortality after pancreatic resection. a systematic review and an evaluation of intervention in The Netherlands. Ann Surg. 2005;242:781–90.CrossRefPubMed van Heek NT, Kuhlmann KFD, Scholten RJ, et al. Hospital volume and mortality after pancreatic resection. a systematic review and an evaluation of intervention in The Netherlands. Ann Surg. 2005;242:781–90.CrossRefPubMed
27.
Zurück zum Zitat Gutierrez JC, Perez EA, Moffat FL, et al. Should soft tissue sarcomas be treated at high- volume centers? An analysis of 4205 patients. Ann Surg. 2007;245:952–8.CrossRefPubMed Gutierrez JC, Perez EA, Moffat FL, et al. Should soft tissue sarcomas be treated at high- volume centers? An analysis of 4205 patients. Ann Surg. 2007;245:952–8.CrossRefPubMed
28.
Zurück zum Zitat Kawaguchi N, Ahmed AR, Matsumoto S, et al. The concept of curative margins in surgery for bone and soft tissue sarcoma. Clin Orthop. 2004;419:165–72.CrossRefPubMed Kawaguchi N, Ahmed AR, Matsumoto S, et al. The concept of curative margins in surgery for bone and soft tissue sarcoma. Clin Orthop. 2004;419:165–72.CrossRefPubMed
29.
Zurück zum Zitat Thomas-Tikhonenko A, Hunter CA. Infection and cancer: the common vein cytokine. Growth Factor Rev. 2003;14:67–77.CrossRef Thomas-Tikhonenko A, Hunter CA. Infection and cancer: the common vein cytokine. Growth Factor Rev. 2003;14:67–77.CrossRef
30.
Zurück zum Zitat Koelmel K, Pfahlberg A, Mastrangelo G, et al. Infections and melanoma risk: results of a multicenter EORTC case study. Melanoma Res. 1999;9:511–9. Koelmel K, Pfahlberg A, Mastrangelo G, et al. Infections and melanoma risk: results of a multicenter EORTC case study. Melanoma Res. 1999;9:511–9.
31.
Zurück zum Zitat Jeys LM, Grimer RJ, Carter SR, et al. Post operative infection and increased survival in osteosarcoma patients: are they associated? Ann Surg Oncol. 2007;14:2887–95.PubMedCrossRef Jeys LM, Grimer RJ, Carter SR, et al. Post operative infection and increased survival in osteosarcoma patients: are they associated? Ann Surg Oncol. 2007;14:2887–95.PubMedCrossRef
32.
Zurück zum Zitat Amato AC, Pescatori M. Effect of peri-operative blood transfusions on recurrence of colorectal cancer: meta-analysis stratified on risk factors. Dis Colon Rectum. 1998;41:570–85.CrossRefPubMed Amato AC, Pescatori M. Effect of peri-operative blood transfusions on recurrence of colorectal cancer: meta-analysis stratified on risk factors. Dis Colon Rectum. 1998;41:570–85.CrossRefPubMed
33.
Zurück zum Zitat Ojima T, Iwahashi M, Nakamori M, et al. Association of allogeneic blood transfusions and long-term survival of patients with gastric cancer after curative gastrectomy. J Gastrointest Surg. 2009;13:1821–30.CrossRefPubMed Ojima T, Iwahashi M, Nakamori M, et al. Association of allogeneic blood transfusions and long-term survival of patients with gastric cancer after curative gastrectomy. J Gastrointest Surg. 2009;13:1821–30.CrossRefPubMed
Metadaten
Titel
Aggressive Surgery in Retroperitoneal Soft Tissue Sarcoma Carried Out at High-Volume Centers is Safe and is Associated With Improved Local Control
verfasst von
Sylvie Bonvalot, MD, PhD
Rosalba Miceli, PhD
Mattia Berselli, MD
Sylvain Causeret, MD
Chiara Colombo, MD
Luigi Mariani, MD
Hatem Bouzaiene, MD
Cécile Le Péchoux, MD
Paolo Giovanni Casali, MD
Axel Le Cesne, MD
Marco Fiore, MD
Alessandro Gronchi, MD
Publikationsdatum
01.06.2010
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 6/2010
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-1057-5

Weitere Artikel der Ausgabe 6/2010

Annals of Surgical Oncology 6/2010 Zur Ausgabe

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

Real-World-Daten sprechen eher für Dupilumab als für Op.

14.05.2024 Rhinosinusitis Nachrichten

Zur Behandlung schwerer Formen der chronischen Rhinosinusitis mit Nasenpolypen (CRSwNP) stehen seit Kurzem verschiedene Behandlungsmethoden zur Verfügung, darunter Biologika, wie Dupilumab, und die endoskopische Sinuschirurgie (ESS). Beim Vergleich der beiden Therapieoptionen war Dupilumab leicht im Vorteil.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.